Přístupnostní navigace
E-application
Search Search Close
Publication detail
ROSLI, N. FOJTŮ, M. FISHER, A. PUMERA, M.
Original Title
Graphene Oxide Nanoplatelets Potentiate Anticancer Effect of Cisplatin in Human Lung Cancer Cells
Type
journal article in Web of Science
Language
English
Original Abstract
Graphene oxide (GO) has been widely explored by many in drug delivery strategies and toxicity assays. The toxicity of graphene oxide depends on the size of the sheets. Smaller sheets show lower toxicity, a quality which is essential for utilization in biomedical applications. However, despite vast research on GO, anticancer properties and drug carrier capabilities of graphene oxide nanoplatelets have yet to be fully explored. Herein, we have uniquely prepared graphene oxide nanoplatelets (GONPs) from well-defined stacked graphite nanofibers (SGNF) with a base of 50 x 50 nm(2) for toxicity and drug potentiation studies when coadministered with the chemotherapeutic drug cisplatin (CP) in human lung cancer cells, A549 cells. Results obtained from our studies have found that not only were GONPs able to act as drug carriers, but they can also significantly potentiate anticancer effect of CP in A549 cells.
Keywords
TARGETED DELIVERY; CYTOTOXICITY; TOXICITY; NANOCARRIER; LABELS
Authors
ROSLI, N.; FOJTŮ, M.; FISHER, A.; PUMERA, M.
Released
26. 2. 2019
ISBN
0743-7463
Periodical
Langmuir
Year of study
35
Number
8
State
United States of America
Pages from
3176
Pages to
3182
Pages count
7
URL
https://pubs.acs.org/doi/10.1021/acs.langmuir.8b03086
BibTex
@article{BUT158445, author="Nur Farhanah {Rosli} and Michaela {Fojtů} and Adrian C. {Fisher} and Martin {Pumera}", title="Graphene Oxide Nanoplatelets Potentiate Anticancer Effect of Cisplatin in Human Lung Cancer Cells", journal="Langmuir", year="2019", volume="35", number="8", pages="3176--3182", doi="10.1021/acs.langmuir.8b03086", issn="0743-7463", url="https://pubs.acs.org/doi/10.1021/acs.langmuir.8b03086" }